Skip to main content
Equibles

Frazier Life Sciences Management, L.P.

Position in DSGN — Design Therapeutics, Inc.

CIK 1892134 PALO ALTO, CA
Back to DSGN Full portfolio

Position in DSGN

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$26,188,587
+$21,301,607 QoQ
Shares Held
1,809,854
+247.4% QoQ
Ownership
2.89%
of shares outstanding
% of Portfolio
0.57%
of 13F equity value
Holder Rank
#8
of 136 holders
Holding Since
Jun 2024
8 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in DSGN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Frazier Life Sciences Management, L.P. holds $4,497,017,185 across 37 Biotechnology names. DSGN ranks #26 (0.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 MIRM
Mirum Pharmaceuticals, Inc.
 7,679,684 $899,060,605
2 NAMS
NewAmsterdam Pharma Co N.V.
 18,589,235 $623,725,004
3 ERAS
Erasca, Inc.
 24,975,188 $457,545,444
4 MBX
MBX Biosciences, Inc.
 6,652,013 $367,191,117
5 ARQT
Arcutis Biotherapeutics, Inc.
 9,874,511 $258,909,678
6 TRVI
Trevi Therapeutics, Inc.
 9,939,447 $185,370,686
7 KRYS
Krystal Biotech, Inc.
 481,307 $178,887,372
8 MAZE
Maze Therapeutics, Inc.
 5,032,915 $150,182,183

All Filings in DSGN

Export CSV
8 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $26,188,587 1,809,854
2025-12-31 $4,886,980 521,000
2025-09-30 $14,710,208 1,953,547
2025-06-30 $6,583,453 1,953,547
2025-03-31 $7,540,691 1,953,547
2024-12-31 $12,053,384 1,953,547
2024-09-30 $10,181,902 1,892,547
2024-06-30 $4,003,849 1,195,179